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Introduction
Varicella zoster virus (VZV) infection, which causes
chickenpox and herpes zoster (HZ), is a common dis-
ease in the aged and immunocompromised populations.
Myelitis is an uncommon complication of VZV infec-
tion, and it is even rarer in immunocompetent patients.
Prompt diagnosis and early intervention are crucial to
minimize morbidity in HZ keratitis and ophthalmi-
cus,1 but there is a lack of reports to support the same
with respect to HZ myelitis. We describe herein a 
35-year-old woman who was immunocompetent, but
who had HZ that progressed to cervical myelitis.
Case Report
A 35-year-old woman presented with vesicles on the
dermatome of her right T1 spinal nerve innervation,
with spontaneous remission 1 week later, except for per-
sistent numbness and itching sensation. After 1 month,
recurrent vesicular eruption with gradual loss of tem-
perature sensation and proprioception in her right
fingers was noted. In addition, there were pain and
numbness in her right dermatomes from C2 to T1.
Two days later, she could not grasp anything or raise
her right arm. Her neurological examination showed
that the muscle strength in her right shoulder, elbow,
and wrist was decreased (shoulder abduction was grade
3; right elbow and wrist flexion/extension were grade
4). Her other 3 limbs demonstrated normal muscle
strength. Cerebrospinal fluid (CSF) analysis via lum-
bar puncture showed pleocytosis with lymphocytic
predominance (white blood cell count, 25; red blood
cell count, 12; N/L/M, 2/90/8), low protein
(34.6 mg/dL), and normal glucose concentrations
(69 mg/dL, and blood glucose was 103 mg/dL then).
The patient’s serum differential lymphocyte cell counts
were within normal limits (CD3/4/8/10, 62/32/
30/10). Screening tests by enzyme-linked immu-
nosorbent assay for human immunodeficiency virus,
Treponema pallidum hemagglutination, and vari-
cella/zoster (IgG/IgM) were all negative in the
serum and CSF. HZ culture from serum and CSF
yielded negative results as well. Cervical spinal magnetic
resonance imaging (MRI) showed expansive intramed-
ullary lesions with focal swelling, which was compati-
ble with inflammation (Figure 1). Electromyography
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and motor evoked potential (MEP) (performed on
admission day 2) showed no motor function involve-
ment, but somatosensory evoked potential (SSEP)
found an asymmetric cortical response with lower
amplitude during stimulation of the right wrist. The
lesion was located from Erb’s point to the sensory
cortex by electrophysiological studies (Figure 2).
Under the impression of HZ myelitis of the cervical
spinal cord, the patient received a course of acyclovir
treatment that began on admission day 4 (500mg twice
daily intravenously for 7 days and orally for 7 days;
Figure 3). Loss of proprioception and temperature sen-
sation of the right lower limb occurred at that time.
However, the muscle power of the corresponding re-
gion of the right lower limb was normal. The patient’s
gait became unsteady, and she needed to look down
at her right leg movements when attempting to walk.
The deep tendon reflexes were brisk with plantar ex-
tension on the right. Moreover, her neurological func-
tion continuously deteriorated, with urinary retention
and stool incontinence. We also prescribed dexam-
ethasone (5 mg every 8 hours for 10 days) for spinal
cord edema.
Gradual improvement was observed 9 days after the
onset of neurological deficits (day 5 of acyclovir admin-
istration). The sequence of neurological recovery was:
sensory function of the right lower limb (9 days after
the onset of neurological deficits); gait (14 days); uri-
nary/stool incontinence (18 days); and finally, sen-
sory function of the right upper limbs (> 6 months).
General improvement of the patient’s neurological
functions was observed, except that fine movement
impairment of the right hand remained at 6 months’
follow-up.
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Figure 1. Cervical spinal magnetic resonance imaging (1 month after onset of herpes zoster). Multiple expansive intramedullary lesions
with: (A) high signal intensity on sagittal T2-weighted images; (B) low signal intensity on sagittal T1-weighted images; (C) enhanced on
post-contrast medium T1-weighted images; and (D) axial T2-weighted images were demonstrated. Jumping lesions were found at the
level of C1 to C5, with focal edematous change.
J Chin Med Assoc • November 2010 • Vol 73 • No 11 607
Herpes zoster myelitis in a young adult
Vesicle
eruption
−28 1 3
Right upper limb paresthesia
Right upper limb weakness
Gait disturbance
Urinary incontinence
Fecal incontinence
Acyclovir (D4–D18)
Decadron (D1–D2, D9–D18)
Right lower limb: loss of proprioception/temperature
4 5 9 14 18
Onset of
neurological
deficits
> 6 mo
Figure 3. The timetable of the entire admission course. The maximal deficits occurred on admission day 9. The timing of treatment with
acyclovir and dexamethasone is shown.
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Figure 2. Somatosensory evoked potential (SSEP) of the left arm
compared with the right arm. Abnormal median SSEPs were due
to an asymmetric cortical response with lower amplitude during
stimulation of the right wrist.
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Discussion
VZV myelitis is an unusual inflammatory disease that
involves any part of the spinal cord. The frequency of
myelitis during or after varicella or zoster infection is
0.3%,2 and most patients are immunocompromised.
The typical symptoms are paresthesia at a certain level,
paraparesis, quadriparesis, and impaired sphincter func-
tion. In most cases, the vesicular lesions are found
prior to neurological symptoms. However, myelitis as-
sociated with varicella or zoster has been described in
the absence of typical skin lesions.3
In 6 studies of zoster- or varicella-induced myelitis
conducted since 1990, 8 immunocompetent patients
have been reported (Table 1). Most of these 8 patients
were female (6/8), and their ages ranged from 18 to
47 years. Myelitis was located in the cervical spinal cord
in 4 patients, thoracic spinal cord in 3, and both in 1.
The timing of development of myelopathy in relation
to the onset of the vesicles varied from 0 days to sev-
eral months. After administration of acyclovir, the in-
terval prior to symptom improvement ranged from 
3 to 9 days. Complete recovery could be seen in 10 days,
but 4 patients were left with permanent neurological
deficits, such as weakness or numbness, or had even
progressed to encephalitis at 6 months’ follow-up.4–8
According to these previous reports, the diagnosis
of VZV myelitis can be challenging. Although blood
tests, MRI of the spine, and spinal tap can help us to
narrow down the diagnostic possibilities, it is impor-
tant to maintain a high index of suspicion in cases with
typical clinical presentation.9 First, T2-weighted MRI
is the most sensitive imaging modality for VZV myelitis.
There were several focal areas of hyperintensity with
various extents of edema in the T2-weighted images
in our case. VZV myelitis often presents as multiple
lesions that are not restricted to 1 level or adjacent
levels; lesions that span several segments of the spinal
cord have been reported. The lesions can spread
eccentrically from the dorsal ganglia, and the degree
of contrast enhancement can vary without correspon-
dence to clinical improvement.6,10–12 Second, detection
of VZV antibodies in the CSF is a pathognomonic
laboratory finding for the diagnosis of myelitis.
Gilden et al13 reported that polymerase chain reaction
for VZV DNA and antibody in the CSF is always pos-
itive in VZV-associated myelitis. However, VZV anti-
body might be negative in some cases, even with the
high sensitivity of the test.7 In Rosenfeld et al’s case
report,7 the patient had significant clinical presenta-
tion of VZV myelitis, but PCR for VZV DNA and
antibody, viral isolation, and viral culture were all neg-
ative. We suggest that the key to VZV myelitis diagnosis
is clinical manifestations, which are most commonly
the typical vesicular eruptions, followed by neurologi-
cal deterioration (including asymmetrical neurological
findings, initial sensory dysfunction, and late-onset
motor dysfunction).
In terms of electrophysiological evaluations, only
a few studies have used electromyography, SSEP and
MEP as adjuvant diagnostic tools for HZ myelitis.
Ikeda et al14 and Gilden et al6 discussed the decrease
(even loss) of amplitude in SSEP of HZ myelitis pa-
tients. However, motor nerve conduction velocity is
nearly normal, with slightly decreased F wave response.6
The value of SSEP is not only to localize the lesion,
but also to suggest HZ myelitis. In our patient, we
also found dissociation of sensory and motor function
deficits, which has not been reported in the literature.
Moreover, follow-up SSEP (3 months after the onset
of myelopathy) revealed that the sensory nerve was
indeed significantly recovered after treatment, which
was different from myelitis due to other causes. There-
fore, SSEP and MEP might be useful to follow up
VZV myelitis.
Currently, there is no standard treatment for VZV
myelitis. Most researchers have suggested high-dose
acyclovir and steroids, but the optimal dosage remains
controversial, especially for immunocompetent patients.
Table 1 demonstrates the various doses, frequencies,
and routes of administration that have been reported.
Two large controlled studies have clarified the role of
combination therapy of acyclovir and corticosteroids
for VZV infection, and have shown that patients ben-
efited from corticosteroids to reduce the duration of
acute neuritis.15,16 In the literature review of VZV
myelitis in immunocompetent patients, the longer
the interval between onset of myelopathy and admin-
istration of acyclovir/corticosteroids, the slower the
observed improvement, and the longer the recovery
time. There might be residual or permanent neuro-
logical deficits in spite of contemporary treatment,
which does not seem to be correlated with dose, fre-
quency, or administration route of acyclovir and cor-
ticosteroids. Early medical intervention might be the
most important prognostic factor. Correlation of the
above findings with our experience leads us to suggest
that the earlier acyclovir treatment is administered,
the more likely a better neurological recovery can be
anticipated.
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